Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

agalsidase beta

agalsidase beta
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Fabrazyme POWDER FOR INJECTION, INTRAVENOUS 35 mg      

VIEW MORE Enzymes
CLASS
440000

Comments:

Fabrazyme is restricted to outpatient use. An evaluation of patient case and pharmacy administration approval are required.

FABRAZYME is approved for use for a specific patient - to be infused at Outpatient Medical.


Reviewed: May 27, 2014


Last updated: Feb. 25, 2019







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.